Stroke Prevention in Atrial Fibrillation: Where are We Now?
Atrial fibrillation is the commonest arrhythmia worldwide and is a growing problem. AF is responsible for 25% of all strokes, and these patients suffer greater mortality and disability. Warfarin has traditionally been the only successful therapy for stroke prevention, but its limitations have result...
Main Authors: | Yousif Ahmad, Gregory Y.H. Lip |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.4137/CMC.S8976 |
Similar Items
-
Stroke Prevention in Atrial Fibrillation: Where are We Now?
by: Yousif Ahmad, et al.
Published: (2012-02-01) -
Stroke prevention in atrial fibrillation: Where are we now?
by: Gregory Y.H. Lip, MD, FRCP, FESC, FACC
Published: (2015-12-01) -
Atrial fibrillation and stroke prevention: where we are and where we should be
by: Jones, N, et al.
Published: (2018) -
Emerging Tools for Stroke Prevention in Atrial Fibrillation
by: Christos Voukalis, et al.
Published: (2016-02-01) -
Atrial Fibrillation after Cardiac Surgery: Where are we now?
by: Dimpi Patel, et al.
Published: (2008-11-01)